Tim Sheahan and his research team at UNC Chapel Hill have developed an orally taken, antiviral drug to combat SARS-CoV-2. According to their paper, published in Science Translational Medicine this April, the drug has proven effective in animal trials. If all goes well, it could soon be testable in humans. Here, Sheahan delves into some of the pressing issues around the antiviral charge against COVID-19.
